Inovio Pharmaceuticals, Inc. (INO) stock
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.63+0.23 (+16.43%)
Close on Nov 17, 2026Market cap $168.54MP/E –Yield –
Inovio Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Inovio Pharmaceuticals's enterprise value was $84.75M on Nov 11, 2026, against $59.56M a year earlier. Over the last 5 years it ranged from -$105.57M to $654.85M, with a median of $39.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $84.75M | +99.8% |
| 2025 | Dec 31, 2025 | $42.41M | – |
| 2024 | Dec 31, 2024 | -$37.12M | – |
| 2023 | Dec 29, 2023 | -$29.93M | -127.9% |
| 2022 | Dec 30, 2022 | $107.31M | -83.6% |
| 2021 | Dec 31, 2021 | $654.85M | -42.8% |
| 2020 | Dec 31, 2020 | $1.15B | +386.5% |
| 2019 | Dec 31, 2019 | $235.49M | -19.5% |
| 2018 | Dec 31, 2018 | $292.50M | +26.5% |
| 2017 | Dec 29, 2017 | $231.14M | -41.3% |
| 2016 | Dec 30, 2016 | $393.76M | +25.2% |
| 2015 | Dec 31, 2015 | $314.52M | -30.8% |
| 2014 | Dec 31, 2014 | $454.39M | -18.3% |
| 2013 | Dec 31, 2013 | $556.39M | +965.7% |
| 2012 | Dec 31, 2012 | $52.21M | +13.6% |
| 2011 | Jul 29, 2011 | $45.98M | – |
See a number that looks wrong?